07:00 , Aug 14, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Seizures Abhydrolase domain containing 6 (ABHD6) Mouse studies suggest inhibiting ABHD6 could help prevent seizures. In a mouse model of chemical-induced seizures, pretreatment with an...
07:00 , Jun 12, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes Abhydrolase domain containing 6 (ABHD6) Cell culture and mouse studies suggest inhibiting ABHD6 could help treat diabetes. In cultured b cells, ABHD6-targeted siRNA...
08:00 , Nov 14, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Inflammation

Indication Target/marker/pathway Summary Licensing status Publication and contact information Inflammation Inflammation Abhydrolase domain containing 6 (ABHD6) Cell culture and mouse studies suggest inhibiting ABHD6 could help treat chronic inflammation. In several types of cultured lipopolysaccharide...
07:00 , Apr 29, 2013 |  BC Week In Review  |  Company News

AmorChem, Universit de Montreal deal

Life science VC fund AmorChem and the university's Univalor commercialization arm partnered to discover and develop drugs against abhydrolase domain containing 6 (ABHD6) to treat Type II diabetes. AmorChem's medicinal chemistry contract-research subsidiary NuChem Therapeutics...